Emerging biomarkers and metabolomics for assessing toxic nephropathy and acute kidney injury (AKI) in neonatology

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Mussap, M ^a   Noto, A ^b   Fanos, V ^b   Van Den Anker, J N ^c  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CREATININE; EPIDERMAL GROWTH FACTOR; KIDNEY INJURY MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ACUTE PHASE PROTEIN; HAVCR1 PROTEIN, HUMAN; LCN2 PROTEIN, HUMAN; LIPOCALIN; MEMBRANE PROTEIN; ONCOPROTEIN; VIRUS RECEPTOR;

ACUTE KIDNEY FAILURE; CREATININE BLOOD LEVEL; DNA MODIFICATION; DRUG INDUCED DISEASE; GENOMICS; HUMAN; HUMAN GENOME; KIDNEY DEVELOPMENT; KIDNEY INJURY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITE; METABOLOMICS; NEPHROTOXICITY; NEWBORN; NEWBORN DISEASE; PATHOGENESIS; PERINATAL PERIOD; PHENOTYPE; PREMATURITY; PROTEOMICS; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; TISSUE REPAIR; TRANSCRIPTOMICS; URINALYSIS; CHEMICALLY INDUCED; DIAGNOSTIC USE; NEONATOLOGY; PATHOLOGY; PROCEDURES; URINE;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; HUMANS; LIPOCALINS; MASS SPECTROMETRY; MEMBRANE GLYCOPROTEINS; METABOLOMICS; NEONATOLOGY; PROTO-ONCOGENE PROTEINS; RECEPTORS, VIRUS;

EID: 84903625326     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/602526     Document Type: Review

References (177)

1. de Jesus L. C., Pappas A., Shankaran S., Kendrick D., Das A., Higgins R. D., Bell E. F., Stoll B. J., Laptook A. R., Walsh M. C., Risk factors for post-neonatal intensive care unit discharge mortality among extremely low birth weight infants. Journal of Pediatrics 2012 161 1 70.e2 74.e2 2-s2.0-84862770071 10.1016/j.jpeds.2011.12.038
2. Cerda J., Oliguria: an earlier and accurate biomarker of acute kidney injury. Kidney International 2011 80 7 699 701 2-s2.0-80052826935 10.1038/ki.2011.177
3. DeSanto N. G., Capasso G., Anastasio P., Coppola S., Policastro M., Bellini L., Siciliano A., Renal functional reserve in children with and without renal disease. Nephron 1991 59 1 1 6 2-s2.0-0025773578
4. Hellerstein S., Berenbom M., Erwin P., Wilson N., DiMaggio S., Measurement of renal functional reserve in children. Pediatric Nephrology 2004 19 10 1132 1136 2-s2.0-4844226081 10.1007/s00467-004-1550-9 (Pubitemid 39317518)
5. Akcan-Arikan A., Zappitelli M., Loftis L. L., Washburn K. K., Jefferson L. S., Goldstein S. L., Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney International 2007 71 10 1028 1035 2-s2.0-34248390897 10.1038/sj.ki.5002231 (Pubitemid 46741996)
6. Sutherland M. R., Gubhaju L., Black M. J., Stereological assessment of renal development in a baboon model of preterm birth. Journal of the American Society of Nephrology 2011 22, supplemnt 1 1365 1374 10.1159/000327073
7. Solhaug M. J., Bolger P. M., Jose P. A., The developing kidney and environmental toxins. Pediatrics 2004 113 4 1084 1091 2-s2.0-1842429805 (Pubitemid 38437362)
8. Sakurada K., Environmental epigenetic modifications and reprogramming-recalcitrant genes. Stem Cell Research 2010 4 3 157 164 2-s2.0-77952288039 10.1016/j.scr.2010.01.001
9. Puddu M., Fanos V., Podda F., Zaffanello M., The kidney from prenatal to adult life: Perinatal programming and reduction of number of nephrons during development. American Journal of Nephrology 2009 30 2 162 170 2-s2.0-63349089705 10.1159/000211324
10. Fanos V., Puddu M., Reali A., Atzei A., Zaffanello M., Perinatal nutrient restriction reduces nephron endowment increasing renal morbidity in adulthood: a review. Early Human Development 2010 86 1 S37 S42 2-s2.0-77957941286 10.1016/j.earlhumdev.2010.01.007
11. Faa G., Gerosa C., Fanni D., Nemolato S., Locci A., Cabras T., Marinelli V., Puddu M., Zaffanello M., Monga G., Fanos V., Marked interindividual variability in renal maturation of preterm infants: lessons from autopsy. The Journal of Maternal-Fetal & Neonatal Medicine 2010 23 3 129 133 2-s2.0-77957945512 10.3109/14767058.2010.510646
12. Faa G., Gerosa C., Fanni D., Monga G., Zaffanello M., Van Eyken P., Fanos V., Morphogenesis and molecular mechanisms involved in human kidney development. Journal of Cellular Physiology 2012 227 3 1257 1268 2-s2.0-84155184184 10.1002/jcp.22985
13. Chiou W. L., Hsu F. H., Pharmacokinetics of creatinine in man and its implications in the monitoring of renal function and in dosage regimen modifications in patients with renal insufficiency. Journal of Clinical Pharmacology 1975 15 5-6 427 434 2-s2.0-0016681963
14. Moran S. M., Myers B. D., Course of acute renal failure studied by a model of creatinine kinetics. Kidney International 1985 27 6 928 937 2-s2.0-0021869646 (Pubitemid 15035559)
15. Doi K., Yuen P. S. T., Eisner C., Hu X., Leelahavanichkul A., Schnermann J., Star R. A., Reduced production of creatinine limits its use as marker of kidney injury in sepsis. Journal of the American Society of Nephrology 2009 20 6 1217 1221 2-s2.0-67449085987 10.1681/ASN.2008060617
16. Waikar S. S., Bonventre J. V., Creatinine kinetics and the definition of acute kidney injury. Journal of the American Society of Nephrology 2009 20 3 672 679 2-s2.0-62149133455 10.1681/ASN.2008070669
17. Coca S. G., Peixoto A. J., Garg A. X., Krumholz H. M., Parikh C. R., The prognostic importance of a small acute decrement in kidney function in hospitalized patients: a systematic review and meta-analysis. American Journal of Kidney Diseases 2007 50 5 712 720 2-s2.0-35348884792 10.1053/j.ajkd.2007.07. 018 (Pubitemid 47588552)
18. Mehta R. L., Biomarker explorations in acute kidney injury: the journey continues. Kidney International 2011 80 4 332 334 2-s2.0-80052189845 10.1038/ki.2011.181
19. Rachoin J.-S., Daher R., Moussallem C., Milcarek B., Hunter K., Schorr C., Abboud M., Henry P., Weisberg L. S., The fallacy of the BUN: creatinine ratio in critically ill patients. Nephrology Dialysis Transplantation 2012 27 6 2248 2254 2-s2.0-84861855987 10.1093/ndt/gfr705
20. Chambers J. C., Zhang W., Lord G. M., Genetic loci influencing kidney function and chronic kidney disease. Nature Genetics 2010 42 5 373 375
21. Luttropp K., Lindholm B., Carrero J. J., Glorieux G., Schepers E., Vanholder R., Schalling M., Stenvinkel P., Nordfors L., Genetics/genomics in chronic kidney disease-towards personalized medicine? Seminars in Dialysis 2009 22 4 417 422 2-s2.0-69249121990 10.1111/j.1525-139X.2009.00592.x
22. Schena F. P., Cerullo G., Torres D. D., Zaza G., Cox S., Bisceglia L., Scolari F., Frascà G., Ghiggeri G. M., Amoroso A., Schena F. P., Searching for IgA nephropathy candidate genes: genetic studies combined with high throughput innovative investigations. Contributions to Nephrology 2007 157 80 89 2-s2.0-34249053524 10.1159/0000102308
23. Nordfors L., Luttropp K., Carrero J. J., Witasp A., Stenvinkel P., Lindholm B., Schalling M., Genetic studies in chronic kidney disease: basic concepts. Journal of Nephrology 2012 25 2 141 149 2-s2.0-84863311137 10.5301/jn.5000145
24. Devarajan P., Mishra J., Supavekin S., Patterson L. T., Potter S. S., Gene expression in early ischemic renal injury: clues towards pathogenesis, biomarker discovery, and novel therapeutics. Molecular Genetics and Metabolism 2003 80 4 365 376 2-s2.0-0344924850 10.1016/j.ymgme.2003.09.012 (Pubitemid 37491197)
25. Nistala R., Hayden M. R., Demarco V. G., Prenatal programming and epigenetics in the genesis of the cardiorenal syndrome. CardioRenal Medicine 2011 1 4 243 254 10.1159/000332756
26. Jirtle R. L., Skinner M. K., Environmental epigenomics and disease susceptibility. Nature Reviews Genetics 2007 8 4 253 262 2-s2.0-33947310031 10.1038/nrg2045 (Pubitemid 46439287)
27. Skinner M. K., Environmental epigenomics and disease susceptibility. The EMBO Reports 2011 12 7 620 622 2-s2.0-79959965712 10.1038/embor.2011.125
28. Goldberg A. D., Allis C. D., Bernstein E., Epigenetics: a landscape takes shape. Cell 2007 128 4 635 638 2-s2.0-33847047461 10.1016/j.cell.2007.02.006 (Pubitemid 46273578)
29. Feinberg A. P., Epigenetics at the epicenter of modern medicine. Journal of the American Medical Association 2008 299 11 1345 1350 2-s2.0-40949093544 10.1001/jama.299.11.1345 (Pubitemid 351439080)
30. Pujadas E., Feinberg A. P., Regulated noise in the epigenetic landscape of development and disease. Cell 2012 148 6 1123 1131 2-s2.0-84858414016 10.1016/j.cell.2012.02.045
31. Feinberg A. P., Epigenomics reveals a functional genome anatomy and a new approach to common disease. Nature Biotechnology 2010 28 10 1049 1052 2-s2.0-77957965145 10.1038/nbt1010-1049
32. Jenuwein T., Allis C. D., Translating the histone code. Science 2001 293 5532 1074 1080 2-s2.0-0035839136 10.1126/science.1063127 (Pubitemid 32758077)
33. Feinberg A. P., Phenotypic plasticity and the epigenetics of human disease. Nature 2007 447 7143 433 440 2-s2.0-34249275353 10.1038/nature05919 (Pubitemid 46816750)
34. Liakopoulos V., Georgianos P. I., Eleftheriadis T., Sarafidis P. A., Epigenetic mechanisms and kidney diseases. Current Medicinal Chemistry 2011 18 12 1733 1739 2-s2.0-79955676421 10.2174/092986711795496827
35. Dwivedi R. S., Herman J. G., McCaffrey T. A., Raj D. S. C., Beyond genetics: epigenetic code in chronic kidney disease. Kidney International 2011 79 1 23 32 2-s2.0-78650270964 10.1038/ki.2010.335
36. Ling X. B., Sylvester K. G., Proteomics and biomarkers in neonatology. NeoReviews 2011 12 10 e585 e591 2-s2.0-80053901590 10.1542/neo.12-10-e585
37. Hortin G. L., Sviridov D., Diagnostic potential for urinary proteomics. Pharmacogenomics 2007 8 3 237 255 2-s2.0-33947574141 10.2217/14622416.8.3.237 (Pubitemid 46477735)
38. Gygi S. P., Aebersold R., Mass spectrometry and proteomics. Current Opinion in Chemical Biology 2000 4 5 489 494 2-s2.0-0033772588 10.1016/S1367-5931(00)00121-6
39. Petricoin E. F., Ardekani A. M., Hitt B. A., Use of proteomic patterns in serum to identify ovarian cancer. The Lancet 2002 359 9306 572 577 (Pubitemid 34178440)
40. Richter R., Schulz-Knappe P., Schrader M., Ständker L., Jürgens M., Tammen H., Forssmann W.-G., Composition of the peptide fraction in human blood plasma: database of circulating human peptides. Journal of Chromatography B: Biomedical Sciences and Applications 1999 726 1-2 25 35 2-s2.0-0032892697 10.1016/S0378-4347(99)00012-2 (Pubitemid 29187202)
41. Balog C. I., Hensbergen P. J., Derks R., Verweij J. J., Van Dam G. J., Vennervald B. J., Deelder A. M., Mayboroda O. A., Novel automated biomarker discovery work flow for urinary peptidomics. Clinical Chemistry 2009 55 1 117 125 2-s2.0-58149252077 10.1373/clinchem.2008.108795
42. Norden A. G. W., Rodriguez-Cutillas P., Unwin R. J., Clinical urinary peptidomics: learning to walk before we can run. Clinical Chemistry 2007 53 3 375 376 2-s2.0-33947402667 10.1373/clinchem.2006.084038 (Pubitemid 46447931)
43. Fiedler G. M., Baumann S., Leichtle A., Oltmann A., Kase J., Thiery J., Ceglarek U., Standardized peptidome profiling of human urine by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clinical Chemistry 2007 53 3 421 428 2-s2.0-33947396353 10.1373/clinchem.2006.077834 (Pubitemid 46447938)
44. Devarajan P., Emerging urinary biomarkers in the diagnosis of acute kidney injury. Expert Opinion on Medical Diagnostics 2008 2 4 387 398 2-s2.0-70449733186 10.1517/17530059.2.4.387 (Pubitemid 351659225)
45. Xu E. Y., Schaefer W. H., Xu Q., Metabolomics in pharmaceutical research and development: metabolites, mechanisms and pathways. Current Opinion in Drug Discovery and Development 2009 12 1 40 52 2-s2.0-58449117420
46. Schnackenberg L. K., Global metabolic profiling and its role in systems biology to advance personalized medicine in the 21st century. Expert Review of Molecular Diagnostics 2007 7 3 247 259 2-s2.0-34249020844 10.1586/14737159.7.3. 247 (Pubitemid 46798615)
47. Nicholson J. K., Lindon J. C., Holmes E., 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999 29 11 1181 1189 2-s2.0-0032694577
48. Lindon J. C., Nicholson J. K., Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics. Annual Review of Analytical Chemistry 2008 1 1 45 69 2-s2.0-66349087823 10.1146/annurev.anchem.1. 031207.113026
49. Oliver S. G., Winson M. K., Kell D. B., Baganz F., Systematic functional analysis of the yeast genome. Trends in Biotechnology 1998 16 9 373 378 2-s2.0-0032168794 10.1016/S0167-7799(98)01214-1 (Pubitemid 28410425)
50. Goodacre R., Vaidyanathan S., Dunn W. B., Harrigan G. G., Kell D. B., Metabolomics by numbers: acquiring and understanding global metabolite data. Trends in Biotechnology 2004 22 5 245 252 2-s2.0-1942470073 10.1016/j.tibtech. 2004.03.007 (Pubitemid 38515742)
51. Christians U., Albuisson J., Klawitter J., Klawitter J., Edelstein C. L., The role of metabolomics in the study of kidney diseases and in the development of diagnostic tools. Biomarkers in Kidney Disease 2011 San Francisco, Calif, USA Elsevier Academic Press 39 100
52. Oldiges M., Lütz S., Pflug S., Schroer K., Stein N., Wiendahl C., Metabolomics: current state and evolving methodologies and tools. Applied Microbiology and Biotechnology 2007 76 3 495 511 2-s2.0-34548025085 10.1007/s00253-007-1029-2 (Pubitemid 47283107)
53. Griffiths W. J., Wang Y., Mass spectrometry: from proteomics to metabolomics and lipidomics. Chemical Society Reviews 2009 38 7 1882 1896 2-s2.0-68949157005 10.1039/b618553n
54. Wishart D. S., Tzur D., Knox C., Eisner R., Guo A. C., Young N., Cheng D., Jewell K., Arndt D., Sawhney S., Fung C., Nikolai L., Lewis M., Coutouly M.-A., Forsythe I., Tang P., Shrivastava S., Jeroncic K., Stothard P., Amegbey G., Block D., Hau D. D., Wagner J., Miniaci J., Clements M., Gebremedhin M., Guo N., Zhang Y., Duggan G. E., MacInnis G. D., Weljie A. M., Dowlatabadi R., Bamforth F., Clive D., Greiner R., Li L., Marrie T., Sykes B. D., Vogel H. J., Querengesser L., HMDB: the human metabolome database. Nucleic Acids Research 2007 35, supplement 1 D521 D526 2-s2.0-33846088138 10.1093/nar/gkl923 (Pubitemid 46056263)
55. Wishart D. S., Knox C., Guo A. C., Eisner R., Young N., Gautam B., Hau D. D., Psychogios N., Dong E., Bouatra S., Mandal R., Sinelnikov I., Xia J., Jia L., Cruz J. A., Lim E., Sobsey C. A., Shrivastava S., Huang P., Liu P., Fang L., Peng J., Fradette R., Cheng D., Tzur D., Clements M., Lewis A., de souza A., Zuniga A., Dawe M., Xiong Y., Clive D., Greiner R., Nazyrova A., Shaykhutdinov R., Li L., Vogel H. J., Forsythei I., HMDB: a knowledgebase for the human metabolome. Nucleic Acids Research 2009 37, supplement 1 1 D603 D610 2-s2.0-58149202163 10.1093/nar/gkn810
56. Reo N. V., NMR-based metabolomics. Drug and Chemical Toxicology 2002 25 4 375 382 2-s2.0-0036384102 10.1081/DCT-120014789
57. Fonville J. M., Maheir A. D., Coen M., Holmes E., Lindon J. C., Nicholson J. K., Evaluation of full-resolution J-resolved1H NMR projections of biofluids for metabonomics information retrieval and biomarker identification. Analytical Chemistry 2010 82 5 1811 1821 2-s2.0-77749324192 10.1021/ac902443k
58. Brown M., Wedge D. C., Goodacre R., Kell D. B., Baker P. N., Kenny L. C., Mamas M. A., Neyses L., Dunn W. B., Automated workflows for accurate mass-based putative metabolite identification in LC/MS-derived metabolomic datasets. Bioinformatics 2011 27 8 1108 1112 2-s2.0-79954519624 10.1093/bioinformatics/ btr079
59. Brown M., Dunn W. B., Dobson P., Patel Y., Winder C. L., Francis-Mcintyre S., Begley P., Carroll K., Broadhurst D., Tseng A., Swainston N., Spasic I., Goodacre R., Kell D. B., Mass spectrometry tools and metabolite-specific databases for molecular identification in metabolomics. Analyst 2009 134 7 1322 1332 2-s2.0-67649834742 10.1039/b901179j
60. Beckonert O., Keun H. C., Ebbels T. M. D., Bundy J., Holmes E., Lindon J. C., Nicholson J. K., Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nature protocols 2007 2 11 2692 2703 2-s2.0-39149126712 10.1038/nprot.2007.376
61. Khoo S. H. G., Al-Rubeai M., Metabolomics as a complementary tool in cell culture. Biotechnology and Applied Biochemistry 2007 47 2 71 84 2-s2.0-34249890793 10.1042/BA20060221 (Pubitemid 46867107)
62. Pan Z., Raftery D., Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics. Analytical and Bioanalytical Chemistry 2007 387 2 525 527 2-s2.0-33846109344 10.1007/s00216-006-0687-8 (Pubitemid 46067468)
63. Pasikanti K. K., Ho P. C., Chan E. C. Y., Gas chromatography/mass spectrometry in metabolic profiling of biological fluids. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 2008 871 2 202 211 2-s2.0-48849114188 10.1016/j.jchromb.2008.04.033
64. Ellis D. I., Goodacre R., Metabolic fingerprinting in disease diagnosis: biomedical applications of infrared and Raman spectroscopy. Analyst 2006 131 8 875 885 2-s2.0-33746449986 10.1039/b602376m (Pubitemid 44126542)
65. Krafft C., Steiner G., Beleites C., Salzer R., Disease recognition by infrared and Raman spectroscopy. Journal of Biophotonics 2009 2 1-2 13 28 2-s2.0-61349099647 10.1002/jbio.200810024
66. Rifai N., Gillette M. A., Carr S. A., Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nature Biotechnology 2006 24 8 971 983 2-s2.0-33747030845 10.1038/nbt1235 (Pubitemid 44215392)
67. Gika H. G., Theodoridis G. A., Wilson I. D., Liquid chromatography and ultra-performance liquid chromatography-mass spectrometry fingerprinting of human urine. Sample stability under different handling and storage conditions for metabonomics studies. Journal of Chromatography A 2008 1189 1-2 314 322 2-s2.0-41949086183 10.1016/j.chroma.2007.10.066
68. Christians U., Klawitter J., Klawitter J., Brunner N., Schmitz V., Biomarkers of immunosuppressant organ toxicity after transplantation: status, concepts and misconceptions. Expert Opinion on Drug Metabolism and Toxicology 2011 7 2 175 200 2-s2.0-79952171650 10.1517/17425255.2011.544249
69. Niemann C. U., Serkova N. J., Biochemical mechanisms of nephrotoxicity: application for metabolomics. Expert Opinion on Drug Metabolism and Toxicology 2007 3 4 527 544 2-s2.0-35448976526 10.1517/17425225.3.4.527 (Pubitemid 351324962)
70. Wishart D., Metabolomics: a complementary tool in renal transplantation. Contributions to Nephrology 2008 160 76 87 2-s2.0-48949096538 10.1159/000125935
71. Chen J., Wen H., Liu J., Yu C., Zhao X., Shi X., Xu G., Metabonomics study of the acute graft rejection in rat renal transplantation using reversed-phase liquid chromatography and hydrophilic interaction chromatography coupled with mass spectrometry. Molecular BioSystems 2012 8 3 871 878 2-s2.0-84863124048 10.1039/c2mb05454j
72. Roberts R., Rodriguez W., Murphy D., Crescenzi T., Pediatric drug labeling: improving the safety and efficacy of pediatric therapies. Journal of the American Medical Association 2003 290 7 905 911 2-s2.0-0042195862 10.1001/jama.290.7.905 (Pubitemid 37430462)
73. Fanos V., Barberini L., Antonucci R., Atzori L., Metabolomics in neonatology and pediatrics. Clinical Biochemistry 2011 44 7 452 454 2-s2.0-79955144383 10.1016/j.clinbiochem.2011.03.006
74. Fanos V., Antonucci R., Barberini L., Atzori L., Chapter 7. Urinary metabolomics in newborns and Infants. Advances in Clinical Chemistry 2012 58 193 223 2-s2.0-84862571524 10.1016/B978-0-12-394383-5.00013-8
75. Fanos V., Antonucci R., Barberini L., Noto A., Atzori L., Clinical application of metabolomics in neonatology. The Journal of Maternal-Fetal & Neonatal Medicine 2012 25 1 104 109 2-s2.0-84859386415 10.3109/14767058.2012. 663198
76. Atzori L., Antonucci R., Barberini L., Locci E., Marincola F. C., Scano P., Cortesi P., Agostiniani R., Defraia R., Weljie A., Gazzolo D., Lai A., Fanos V., 1H NMR-based metabolomic analysis of urine from preterm and term neonates. Frontiers in Bioscience 2011 3 3 1005 1012 2-s2.0-80053283504
77. Atzori L., Griffin J. L., Noto A., Fanos V., Review metabolomics: a new approach to drug delivery in perinatology. Current Medicinal Chemistry 2012 19 27 4654 4661 2-s2.0-84875263481
78. Fanos V., Barberini L., Antonucci R., Atzori L., Pharma-metabolomics in neonatology: is it a dream or a fact? Current Pharmaceutical Design 2012 18 21 2996 3006 2-s2.0-84859383638
79. Atzori L., Antonucci R., Barberini L., Locci E., Marincola F. C., Scano P., Cortesi P., Agostiniani R., Weljie A., Lai A., Fanos V., 1H NMR-based metabolic profiling of urine from children with nephrouropathies. Frontiers in Bioscience 2010 2 2 725 732 2-s2.0-77954466386
80. Dess A., Atzori L., Noto A., Adriaan Visser G. H., Gazzolo D., Zanardo V., Barberini L., Puddu M., Ottonello G., Atzei A., Magistris A. D., Lussu M., Murgia F., Fanos V., Metabolomics in newborns with intrauterine growth retardation (IUGR): urine reveals markers of metabolic syndrome. The Journal of Maternal-Fetal & Neonatal Medicine 2011 24, supplement 2 35 39 2-s2.0-80053285264 10.3109/14767058.2011.605868
81. Fabiano A., Gazzolo D., Zimmermann L. J. I., Gavilanes A. W. D., Paolillo P., Fanos V., Caboni P., Barberini L., Noto A., Atzori L., Metabolomic analysis of bronchoalveolar lavage fluid in preterm infants complicated by respiratory distress syndrome: preliminary results. The Journal of Maternal-Fetal & Neonatal Medicine 2011 24, supplement 2 55 58 2-s2.0-84857066070
82. Atzei A., Atzori L., Moretti C., Barberini L., Noto A., Ottonello G., Pusceddu E., Fanos V., Metabolomics in paediatric respiratory diseases and bronchiolitis. The Journal of Maternal-Fetal & Neonatal Medicine 2011 24 2 59 62 2-s2.0-80053513147 10.3109/14767058.2011.607012
83. Atzori L., Mussap M., Noto A., Barberini L., Puddu M., Coni E., Murgia F., Lussu M., Fanos V., Clinical metabolomics and urinary NGAL for the early prediction of chronic kidney disease in healthy adults born ELBW. The Journal of Maternal-Fetal & Neonatal Medicine 2011 24 40 43 2-s2.0-84857090554
84. Weiss R. H., Kim K., Metabolomics in the study of kidney diseases. Nature Reviews Nephrology 2012 8 1 22 33 2-s2.0-84455169596 10.1038/nrneph.2011.152
85. Hawkins R. D., Hon G. C., Ren B., Next-generation genomics: an integrative approach. Nature Reviews Genetics 2010 11 7 476 486 2-s2.0-77953808473 10.1038/nrg2795
86. Goodsaid F. M., Blank M., Dieterle F., Harlow P., Hausner E., Sistare F., Thompson A., Vonderscher J., Novel biomarkers of acute kidney toxicity. Clinical Pharmacology and Therapeutics 2009 86 5 490 496 2-s2.0-70350215904 10.1038/clpt.2009.149
87. Kjeldsen L., Johnsen A. H., Sengelov H., Borregaard N., Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. The Journal of Biological Chemistry 1993 268 14 10425 10432 2-s2.0-0027256664 (Pubitemid 23150227)
88. Flo T. H., Smith K. D., Sato S., Rodriguez D. J., Holmes M. A., Strong R. K., Akira S., Aderem A., Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 2004 432 7019 917 921 2-s2.0-11144314814 10.1038/nature03104 (Pubitemid 40037155)
89. Mishra J., Mori K., Ma Q., Kelly C., Yang J., Mitsnefes M., Barasch J., Devarajan P., Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. Journal of the American Society of Nephrology 2004 15 12 3073 3082 2-s2.0-9644307879 10.1097/01.ASN.0000145013.44578.45 (Pubitemid 39578839)
90. Mori K., Lee H. T., Rapoport D., Drexler I. R., Foster K., Yang J., Schmidt-Ott K. M., Chen X., Jau Y. L., Weiss S., Mishra J., Cheema F. H., Markowitz G., Suganami T., Sawai K., Mukoyama M., Kunis C., D'Agati V., Devarajan P., Barasch J., Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. The Journal of Clinical Investigation 2005 115 3 610 621 2-s2.0-20044395425 10.1172/JCI200523056 (Pubitemid 40322235)
91. Gwira J. A., Wei F., Ishibe S., Ueland J. M., Barasch J., Cantley L. G., Expression of neutrophil gelatinase-associated lipocalin regulates epithelial morphogenesis in vitro. The Journal of Biological Chemistry 2005 280 9 7875 7882 2-s2.0-14844331424 10.1074/jbc.M413192200 (Pubitemid 40349684)
92. Cowland J. B., Borregaard N., Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics 1997 45 1 17 23 2-s2.0-0031260224 10.1006/geno.1997.4896 (Pubitemid 27449379)
93. Kjeldsen L., Bainton D. F., Sengeløv H., Borregaard N., Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. Blood 1994 83 3 799 807 2-s2.0-0027955338 (Pubitemid 24043742)
94. Friedl A., Stoesz S. P., Buckley P., Gould M. N., Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression. Histochemical Journal 1999 31 7 433 441 2-s2.0-0032799411 10.1023/A:1003708808934 (Pubitemid 29369301)
95. Devarajan P., Neutrophil gelatinase-associated lipocalin: new paths for an old shuttle. Cancer Therapy 2007 5(B) 463 470
96. Tewary P., Redmond C., Clifton M., Neutrophil gelatinase-associated lipocalin (NGAL): endogenous activators of the immune system. The Journal of Immunology 2010 184 89
97. Hvidberg V., Jacobsen C., Strong R. K., Cowland J. B., Moestrup S. K., Borregaard N., The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake. FEBS Letters 2005 579 3 773 777 2-s2.0-12744272449 10.1016/j.febslet.2004.12.031
98. Langelueddecke C., Roussa E., Fenton R. A., Wolff N. A., Lee W.-K., Thévenod F., Lipocalin-2 (24p3/neutrophil gelatinase-associated lipocalin (NGAL)) receptor is expressed in distal nephron and mediates protein endocytosis. The Journal of Biological Chemistry 2012 287 1 159 169 2-s2.0-84855259370 10.1074/jbc.M111.308296
99. Paragas N., Qiu A., Zhang Q., Samstein B., Deng S.-X., Schmidt-Ott K. M., Viltard M., Yu W., Forster C. S., Gong G., Liu Y., Kulkarni R., Mori K., Kalandadze A., Ratner A. J., Devarajan P., Landry D. W., D'Agati V., Lin C.-S., Barasch J., The Ngal reporter mouse detects the response of the kidney to injury in real time. Nature Medicine 2011 17 2 216 222 2-s2.0-79751536146 10.1038/nm.2290
100. Viau A., El Karoui K., Laouari D., Burtin M., Nguyen C., Mori K., Pillebout E., Berger T., Mak T. W., Knebelmann B., Friedlander G., Barasch J., Terzi F., Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. Journal of Clinical Investigation 2010 120 11 4065 4076 2-s2.0-78049434336 10.1172/JCI42004
101. Schmidt-Ott K. M., Mori K., Kalandadze A., Li J.-Y., Paragas N., Nicholas T., Devarajan P., Barasch J., Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia. Current Opinion in Nephrology and Hypertension 2006 15 4 442 449 2-s2.0-33748090237 10.1097/01.mnh.0000232886.81142.58 (Pubitemid 44297988)
102. Schmidt-Ott K. M., Mori K., Jau Y. L., Kalandadze A., Cohen D. J., Devarajan P., Barasch J., Dual action of neutrophil gelatinase-associated lipocalin. Journal of the American Society of Nephrology 2007 18 2 407 413 2-s2.0-33846682720 10.1681/ASN.2006080882 (Pubitemid 46193306)
103. Grenier F. C., Ali S., Syed H., Workman R., Martens F., Liao M., Wang Y., Wong P.-Y., Evaluation of the ARCHITECT urine NGAL assay: assay performance, specimen handling requirements and biological variability. Clinical Biochemistry 2010 43 6 615 620 2-s2.0-77950858129 10.1016/j.clinbiochem.2009.12.008
104. Yan L., Borregaard N., Kjeldsen L., Moses M. A., The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL): modulation of MMP-9 activity by NGAL. The Journal of Biological Chemistry 2001 276 40 37258 37265 2-s2.0-0035813187 10.1074/jbc.M106089200
105. Cai L., Rubin J., Han W., Venge P., Xu S., The origin of multiple molecular forms in urine of HNL/NGAL. Clinical Journal of the American Society of Nephrology 2010 5 12 2229 2235 2-s2.0-78650372095 10.2215/CJN.00980110
106. Hatipoglu S., Sevketoglu E., Gedikbasi A., Yilmaz A., Kiyak A., Mulazimoglu M., Aydogan G., Ozpacaci T., Urinary MMP-9/NGAL complex in children with acute cystitis. Pediatric Nephrology 2011 26 8 1263 1268 2-s2.0-80052443945 10.1007/s00467-011-1856-3
107. Nickolas T. L., Forster C. S., Sise M. E., Barasch N., Valle D. S.-D., Viltard M., Buchen C., Kupferman S., Carnevali M. L., Bennett M., Mattei S., Bovino A., Argentiero L., Magnano A., Devarajan P., Mori K., Erdjument-Bromage H., Tempst P., Allegri L., Barasch J., NGAL (Lcn2) monomer is associated with tubulointerstitial damage in chronic kidney disease. Kidney International 2012 82 6 718 722 2-s2.0-84865784208 10.1038/ki.2012.195
108. Mussap M., Noto A., Fravega M., Fanos V., Urine neutrophil gelatinase-associated lipocalin (uNGAL) and netrin-1: are they effectively improving the clinical management of sepsis-induced acute kidney injury (AKI)? The Journal of Maternal-Fetal & Neonatal Medicine 2011 24, supplement 2 15 17 2-s2.0-84857100224
109. Mishra J., Qing M. A., Prada A., Mitsnefes M., Zahedi K., Yang J., Barasch J., Devarajan P., Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. Journal of the American Society of Nephrology 2003 14 10 2534 2543 2-s2.0-0141678253 10.1097/01.ASN.0000088027.54400.C6 (Pubitemid 37169339)
110. Mishra J., Mori K., Ma Q., Kelly C., Barasch J., Devarajan P., Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. American Journal of Nephrology 2004 24 3 307 315 2-s2.0-4043163418 10.1159/000078452 (Pubitemid 39070114)
111. Haase M., Bellomo R., Devarajan P., Schlattmann P., Haase-Fielitz A., Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. American Journal of Kidney Diseases 2009 54 6 1012 1024 2-s2.0-70449637194 10.1053/j.ajkd.2009.07.020
112. Haase M., Devarajan P., Haase-Fielitz A., Bellomo R., Cruz D. N., Wagener G., Krawczeski C. D., Koyner J. L., Murray P., Zappitelli M., Goldstein S. L., Makris K., Ronco C., Martensson J., Martling C.-R., Venge P., Siew E., Ware L. B., Ikizler T. A., Mertens P. R., The outcome of neutrophil gelatinase- associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. Journal of the American College of Cardiology 2011 57 17 1752 1761 2-s2.0-79955072767 10.1016/j.jacc.2010.11.051
113. Mishra J., Dent C., Tarabishi R., Mitsnefes M. M., Ma Q., Kelly C., Ruff S. M., Zahedi K., Shao M., Bean J., Mori K., Barasch J., Devarajan P., Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. The Lancet 2005 365 9466 1231 1238 2-s2.0-20144388328 10.1016/S0140-6736(05)74811-X (Pubitemid 40469655)
114. Fadel F. I., Abdel Rahman A. M. O., Mohamed M. F., Habib S. A., Ibrahim M. H., Sleem Z. S., Bazaraa H. M., Soliman M. M. A., Plasma neutrophil gelatinase-associated lipocalin as an early biomarker for prediction of acute kidney injury after cardio-pulmonary bypass in pediatric cardiac surgery. Archives of Medical Science 2012 8 2 250 255 2-s2.0-84861471771 10.5114/aoms.2012.28552
115. Ampatzidou F., Koutsogiannidis C.-P., Ananiadou O., Liosi M., Asteri T., Drossos G., Neutrophil gelatinase-associated lipocalin as emerging biomarker of acute renal failure in renal transplant patient after coronary artery bypass surgery. Journal of Cardiovascular Surgery 2012 53 6 805 808 2-s2.0-84862851417
116. Bignami E., Frati E., Ceriotti F., Daverio R., Silvetti S., Landoni G., Marino G., Zangrillo A., Urinary neutrophil gelatinase-associated lipocalin as an early predictor of prolonged intensive care unit stay after cardiac surgery. Annals of Cardiac Anaesthesia 2012 15 1 13 17 2-s2.0-84856830965 10.4103/0971-9784.91470
117. Capuano F., Goracci M., Luciani R., Gentile G., Roscitano A., Benedetto U., Sinatra R., Neutrophil gelatinase-associated lipocalin levels after use of mini-cardiopulmonary bypass system. Interactive Cardiovascular and Thoracic Surgery 2009 9 5 797 801 2-s2.0-70350459486 10.1510/icvts.2009.212266
118. Ho J., Lucy M., Krokhin O., Hayglass K., Pascoe E., Darroch G., Rush D., Nickerson P., Rigatto C., Reslerova M., Mass spectrometry-based proteomic analysis of urine in acute kidney injury following cardiopulmonary bypass: a nested case-control study. American Journal of Kidney Diseases 2009 53 4 584 595 2-s2.0-62749180220 10.1053/j.ajkd.2008.10.037
119. Wagener G., Gubitosa G., Wang S., Borregaard N., Kim M., Lee H. T., Urinary neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery. American Journal of Kidney Diseases 2008 52 3 425 433 2-s2.0-49749100773 10.1053/j.ajkd.2008.05.018
120. Bennett M., Dent C. L., Ma Q., Dastrala S., Grenier F., Workman R., Syed H., Ali S., Barasch J., Devarajan P., Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clinical Journal of the American Society of Nephrology 2008 3 3 665 673 2-s2.0-44649171719 10.2215/CJN.04010907
121. Hall I. E., Yarlagadda S. G., Coca S. G., Wang Z., Doshi M., Devarajan P., Han W. K., Marcus R. J., Parikh C. R., IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. Journal of the American Society of Nephrology 2010 21 1 189 197 2-s2.0-75149180130 10.1681/ASN.2009030264
122. Parikh C. R., Jani A., Mishra J., Ma Q., Kelly C., Barasch J., Edelstein C. L., Devarajan P., Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. American Journal of Transplantation 2006 6 7 1639 1645 2-s2.0-33745399379 10.1111/j.1600-6143.2006. 01352.x (Pubitemid 43945804)
123. Trachtman H., Christen E., Cnaan A., Patrick J., Mai V., Mishra J., Jain A., Bullington N., Devarajan P., Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: a novel marker of renal injury. Pediatric Nephrology 2006 21 7 989 994 2-s2.0-33745108383 10.1007/s00467-006-0146-y (Pubitemid 43885099)
124. Hirsch R., Dent C., Pfriem H., Allen J., Beekman R. H. III, Ma Q., Dastrala S., Bennett M., Mitsnefes M., Devarajan P., NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatric Nephrology 2007 22 12 2089 2095 2-s2.0-36048965159 10.1007/s00467-007-0601-4 (Pubitemid 350090716)
125. Wheeler D. S., Devarajan P., Ma Q., Harmon K., Monaco M., Cvijanovich N., Wong H. R., Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock. Critical Care Medicine 2008 36 4 1297 1303 2-s2.0-41649097463 10.1097/CCM. 0b013e318169245a (Pubitemid 351482681)
126. Lavery A. P., Meinzen-Derr J. K., Anderson E., Ma Q., Bennett M. R., Devarajan P., Schibler K. R., Urinary NGAL in premature infants. Pediatric Research 2008 64 4 423 428 2-s2.0-55049139369 10.1203/PDR.0b013e318181b3b2
127. Huynh T. K., Bateman D. A., Parravicini E., Lorenz J. M., Nemerofsky S. L., Sise M. E., Bowman T. M., Polesana E., Barasch J. M., Reference values of urinary neutrophil gelatinase-associated lipocalin in very low birth weight infants. Pediatric Research 2009 66 5 528 532 2-s2.0-73249124361 10.1203/PDR.0b013e3181baa3dd
128. Parravicini E., Nemerofsky S. L., Michelson K. A., Huynh T. K., Sise M. E., Bateman D. A., Lorenz J. M., Barasch J. M., Urinary neutrophil gelatinase-associated lipocalin is a promising biomarker for late onset culture-positive sepsis in very low birth weight infants. Pediatric Research 2010 67 6 636 640 2-s2.0-77952501093 10.1203/PDR.0b013e3181da75c1
129. Mussap M., Degrandi R., Fravega M., Fanos V., Acute kidney injury in critically ill infants: the role of urine neutrophil gelatinase-associated lipocalin (NGAL). The Journal of Maternal-Fetal & Neonatal Medicine 2010 23 3 70 72 2-s2.0-77957930887 10.3109/14767058.2010.508217
130. Ichimura T., Bonventre J. V., Bailly V., Wei H., Hession C. A., Cate R. L., Sanicola M., Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. The Journal of Biological Chemistry 1998 273 7 4135 4142 2-s2.0-0032512724 10.1074/jbc.273.7.4135 (Pubitemid 28103282)
131. Bailly V., Zhang Z., Meier W., Cate R., Sanicola M., Bonventre J. V., Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration. The Journal of Biological Chemistry 2002 277 42 39739 39748 2-s2.0-0037131165 10.1074/jbc.M200562200 (Pubitemid 35190957)
132. Kuchroo V. K., Umetsu D. T., DeKruyff R. H., Freeman G. J., The TIM gene family: emerging roles in immunity and disease. Nature Reviews Immunology 2003 3 6 454 462 2-s2.0-0038143288 10.1038/nri1111 (Pubitemid 37339185)
133. Kaplan G., Totsuka A., Thompson P., Akatsuka T., Moritsugu Y., Feinstone S. M., Identification of a surface glycoprotein on African green monkey kidney cells as a receptor for hepatitis A virus. The EMBO Journal 1996 15 16 4282 4296 2-s2.0-0029775055 (Pubitemid 26278711)
134. Amin R. P., Vickers A. E., Sistare F., Thompson K. L., Roman R. J., Lawton M., Kramer J., Hamadeh H. K., Collins J., Grissom S., Bennett L., Tucker C. J., Wild S., Kind C., Oreffo V., Davis J. W. II, Curtiss S., Naciff J. M., Cunningham M., Tennant R., Stevens J., Car B., Bertram T. A., Afshari C. A., Identification of putative gene-based markers of renal toxicity. Environmental Health Perspectives 2004 112 4 465 479 2-s2.0-12144290763 (Pubitemid 38404558)
135. Ichimura T., Asseldonk E. J. P. V., Humphreys B. D., Gunaratnam L., Duffield J. S., Bonventre J. V., Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. The Journal of Clinical Investigation 2008 118 5 1657 1668 2-s2.0-43049125804 10.1172/JCI34487 (Pubitemid 351632370)
136. Savill J., Fadok V., Corpse clearance defines the meaning of cell death. Nature 2000 407 6805 784 788 2-s2.0-0034641931 10.1038/35037722
137. Waanders F., Van Timmeren M. M., Stegeman C. A., Bakker S. J. L., Van Goor H., Kidney injury molecule-1 in renal disease. Journal of Pathology 2010 220 1 7 16 2-s2.0-73649105165 10.1002/path.2642
138. Ichimura T., Hung C. C., Yang S. A., Stevens J. L., Bonventre J. V., Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. The American Journal of Physiology: Renal Physiology 2004 286 3 F552 F563 2-s2.0-1242343823 (Pubitemid 38233650)
139. Vaidya V. S., Waikar S. S., Ferguson M. A., Collings F. B., Sunderland K., Gioules C., Bradwin G., Matsouaka R., Betensky R. A., Curhan G. C., Bonventre J. V., Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clinical and Translational Science 2008 1 3 200 208 2-s2.0-67449166685 10.1111/j.1752-8062.2008.00053.x (Pubitemid 352831522)
140. Han W. K., Bailly V., Abichandani R., Thadhani R., Bonventre J. V., Kidney Injury Molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury. Kidney International 2002 62 1 237 244 2-s2.0-0036314217 10.1046/j.1523-1755.2002.00433.x (Pubitemid 34754067)
141. Zhou Y., Vaidya V. S., Brown R. P., Zhang J., Rosenzweig B. A., Thompson K. L., Miller T. J., Bonventre J. V., Goering P. I., Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium. Toxicological Sciences 2008 101 1 159 170 2-s2.0-36949014801 10.1093/toxsci/kfm260 (Pubitemid 350239020)
142. Bonventre J. V., Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure. Journal of the American Society of Nephrology 2003 14 1 S55 S61 2-s2.0-0037836057 (Pubitemid 36687041)
143. Park K. M., Byun J.-Y., Kramers C., Kim J. I., Huang P. L., Bonventre J. V., Inducible nitric-oxide synthase is an important contributor to prolonged protective effects of ischemic preconditioning in the mouse kidney. The Journal of Biological Chemistry 2003 278 29 27256 27266 2-s2.0-0038711510 10.1074/jbc.M301778200 (Pubitemid 36876883)
144. Pérez-Rojas J., Blanco J. A., Cruz C., Trujillo J., Vaidya V. S., Uribe N., Bonventre J. V., Gamba G., Bobadilla N. A., Mineralocorticoid receptor blockade confers renoprotection in preexisting chronic cyclosporine nephrotoxicity. The American Journal of Physiology: Renal Physiology 2007 292 1 F131 F139 2-s2.0-33846210660 10.1152/ajprenal.00147.2006 (Pubitemid 46105252)
145. Prozialeck W. C., Vaidya V. S., Liu J., Waalkes M. P., Edwards J. R., Lamar P. C., Bernard A. M., Dumont X., Bonventre J. V., Kidney injury molecule-1 is an early biomarker of cadmium nephrotoxicity. Kidney International 2007 72 8 985 993 2-s2.0-34948883334 10.1038/sj.ki.5002467 (Pubitemid 47530576)
146. Fanos V., Antonucci R., Zaffanello M., Mussap M., Neonatal drug induced nephrotoxicity: old and next generation biomarkers for early detection and management of neonatal drug-induced nephrotoxicity, with special emphasis on uNGAL and on metabolomics. Current Medicinal Chemistry 2012 19 27 4595 4605
147. Han W. K., Alinani A., Wu C.-L., Michaelson D., Loda M., McGovern F. J., Thadhani R., Bonventre J. V., Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma. Journal of the American Society of Nephrology 2005 16 4 1126 1134 2-s2.0-24344507726 10.1681/ASN.2004070530 (Pubitemid 41710324)
148. Lin F., Zhang P. L., Yang X. J., Shi J., Blasick T., Han W. K., Wang H. L., Shen S. S., Teh B. T., Bonventre J. V., Human kidney injury molecule-1 (hKIM-1): a useful immunohistochemical marker for diagnosing renal cell carcinoma and ovarian clear cell carcinoma. The American Journal of Surgical Pathology 2007 31 3 371 381 2-s2.0-34247589885 10.1097/01.pas.0000213353.95508. 67 (Pubitemid 46673110)
149. Van Timmeren M. M., Bakker S. J. L., Vaidya V. S., Bailly V., Schuurs T. A., Damman J., Stegeman C. A., Bonventre J. V., Van Goor H., Tubular kidney injury molecule-1 in protein-overload nephropathy. The American Journal of Physiology: Renal Physiology 2006 291 2 F456 F464 2-s2.0-33746645922 10.1152/ajprenal.00403.2005 (Pubitemid 44148135)
150. Kuehn E. W., Park K. M., Somlo S., Bonventre J. V., Kidney injury molecule-1 expression in murine polycystic kidney disease. The American Journal of Physiology: Renal Physiology 2002 283 6 F1326 F1336 2-s2.0-0036890193 (Pubitemid 35332662)
151. McIntire J. J., Umetsu S. E., Akbari O., Potter M., Kuchroo V. K., Barsh G. S., Freeman G. J., Umetsu D. T., DeKruyff R. H., Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family. Nature Immunology 2001 2 12 1109 1116 2-s2.0-0035204919 10.1038/ni739 (Pubitemid 33130144)
152. Zhang Z., Humphreys B. D., Bonventre J. V., Shedding of the urinary biomarker kidney injury molecule-1 (KIM-1) is regulated by MAP kinases and juxtamembrane region. Journal of the American Society of Nephrology 2007 18 10 2704 2714 2-s2.0-34948814501 10.1681/ASN.2007030325 (Pubitemid 47531197)
153. Zhang P. L., Rothblum L. I., Han W. K., Blasick T. M., Potdar S., Bonventre J. V., Kidney injury molecule-1 expression in transplant biopsies is a sensitive measure of cell injury. Kidney International 2008 73 5 608 614 2-s2.0-39349098768 10.1038/sj.ki.5002697 (Pubitemid 351264105)
154. Van Timmeren M. M., Vaidya V. S., Van Ree R. M., Oterdoom L. H., De Vries A. P. J., Gans R. O. B., Van Goor H., Stegeman C. A., Bonventre J. V., Bakker S. J. L., High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients. Transplantation 2007 84 12 1625 1630 2-s2.0-37549009988 10.1097/01.tp.0000295982.78039.ef
155. Perco P., Oberbauer R., Kidney injury molecule-1 as a biomarker of acute kidney injury in renal transplant recipients. Nature Clinical Practice Nephrology 2008 4 7 362 363 2-s2.0-46249101407 10.1038/ncpneph0828 (Pubitemid 351913691)
156. Bonventre J. V., Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. Nephrology, Dialysis, Transplantation 2009 24 11 3265 3268 2-s2.0-73649123753 10.1093/ndt/gfp010
157. Huo W., Zhang K., Nie Z., Li Q., Jin F., Kidney injury molecule-1 (KIM-1): a novel kidney-specific injury molecule playing potential double-edged functions in kidney injury. Transplantation Reviews 2010 24 3 143 146 2-s2.0-77954383688 10.1016/j.trre.2010.02.002
158. Bonventre J. V., Vaidya V. S., Schmouder R., Feig P., Dieterle F., Next-generation biomarkers for detecting kidney toxicity. Nature Biotechnology 2010 28 5 436 440 2-s2.0-77952210871 10.1038/nbt0510-436
159. Dieterle F., Sistare F., Goodsaid F., Papaluca M., Ozer J. S., Webb C. P., Baer W., Senagore A., Schipper M. J., Vonderscher J., Sultana S., Gerhold D. L., Phillips J. A., Maurer G., Carl K., Laurie D., Harpur E., Sonee M., Ennulat D., Holder D., Andrews-Cleavenger D., Gu Y.-Z., Thompson K. L., Goering P. L., Vidal J.-M., Abadie E., MacIulaitis R., Jacobson-Kram D., Defelice A. F., Hausner E. A., Blank M., Thompson A., Harlow P., Throckmorton D., Xiao S., Xu N., Taylor W., Vamvakas S., Flamion B., Lima B. S., Kasper P., Pasanen M., Prasad K., Troth S., Bounous D., Robinson-Gravatt D., Betton G., Davis M. A., Akunda J., McDuffie J. E., Suter L., Obert L., Guffroy M., Pinches M., Jayadev S., Blomme E. A., Beushausen S. A., Barlow V. G., Collins N., Waring J., Honor D., Snook S., Lee J., Rossi P., Walker E., Mattes W., Renal biomarker qualification submission: a dialog between the FDA-EMEA and predictive safety testing consortium. Nature Biotechnology 2010 28 5 455 462 2-s2.0-77952138048 10.1038/nbt.1625
160. Waanders F., Vaidya V. S., van Goor H., Leuvenink H., Damman K., Hamming I., Bonventre J. V., Vogt L., Navis G., Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial. American Journal of Kidney Diseases 2009 53 1 16 25 2-s2.0-57649144008 10.1053/j.ajkd.2008.07.021
161. Vaidya V. S., Ramirez V., Ichimura T., Bobadilla N. A., Bonventre J. V., Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. The American Journal of Physiology: Renal Physiology 2006 290 2 F517 F529 2-s2.0-33644870877 10.1152/ajprenal.00291.2005 (Pubitemid 43725006)
162. Liangos O., Perianayagam M. C., Vaidya V. S., Han W. K., Wald R., Tighiouart H., MacKinnon R. W., Li L., Balakrishnan V. S., Pereira B. J. G., Bonventre J. V., Jaber B. L., Urinary N-acetyl- β -(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. Journal of the American Society of Nephrology 2007 18 3 904 912 2-s2.0-33947262956 10.1681/ASN.2006030221 (Pubitemid 46434507)
163. Wasilewska A., Taranta-Janusz K., Dbek W., Zoch-Zwierz W., Kuroczycka-Saniutycz E., KIM-1 and NGAL: new markers of obstructive nephropathy. Pediatric Nephrology 2011 26 4 579 586 2-s2.0-79954443701 10.1007/s00467-011- 1773-5
164. Askenazi D. J., Koralkar R., Levitan E. B., Goldstein S. L., Devarajan P., Khandrika S., Mehta R. L., Ambalavanan N., Baseline values of candidate urine acute kidney injury biomarkers vary by gestational age in premature infants. Pediatric Research 2011 70 3 302 306 2-s2.0-80051764049 10.1203/PDR.0b013e3182275164
165. Sean Eardley K., Cockwell P., Macrophages and progressive tubulointerstitial disease. Kidney International 2005 68 2 437 455 2-s2.0-26944492287 10.1111/j.1523-1755.2005.00422.x (Pubitemid 43323099)
166. Munshi R., Johnson A., Siew E. D., Ikizler T. A., Ware L. B., Wurfel M. M., Himmelfarb J., Zager R. A., MCP-1 gene activation marks acute kidney injury. Journal of the American Society of Nephrology 2011 22 1 165 175 2-s2.0-78651382290 10.1681/ASN.2010060641
167. Grandaliano G., Gesualdo L., Ranieri E., Monno R., Montinaro V., Marra F., Schena F. P., Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: a pathogenetic role in interstitial monocytes recruitment. Journal of the American Society of Nephrology 1996 7 6 906 913 2-s2.0-0030377417 (Pubitemid 27465985)
168. Gesualdo L., Di Paolo S., Calabró A., Milani S., Maiorano E., Ranieri E., Pannarale G., Schena F. P., Expression of epidermal growth factor and its receptor in normal and diseased human kidney: an immunohistochemical and in situ hybridization study. Kidney International 1996 49 3 656 665 2-s2.0-0029968917 (Pubitemid 26093074)
169. Humes H. D., Cieslinski D. A., Coimbra T. M., Messana J. M., Galvao C., Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in postischemic acute renal failure. The Journal of Clinical Investigation 1989 84 6 1757 1761 2-s2.0-0024814755 (Pubitemid 20016178)
170. Chevalier R. L., Goyal S., Wolstenholme J. T., Thornhill B. A., Obstructive nephropathy in the neonatal rat is attenuated by epidermal growth factor. Kidney International 1998 54 1 38 47 2-s2.0-0031807023 10.1046/j.1523-1755.1998.00966.x (Pubitemid 28288017)
171. Plebani M., Fanos V., Mussap M., De Paoli M., Khoory B. J., Padovani E. M., Urinary excretion of human epidermal growth factor in premature infants requiring assisted ventilation over the first week of life. Nephron 1997 76 2 225 226 2-s2.0-0030973363 (Pubitemid 27254653)
172. Fanos V., Pizzini C., Mussap M., Benini D., Plebani M., Urinary epidermal growth factor in different renal conditions in children. Renal Failure 2001 23 3-4 605 610 2-s2.0-0034914608 10.1081/JDI-100104742 (Pubitemid 32692294)
173. Bartoli F., Gesualdo L., Paradies G., Caldarulo E., Infante B., Grandaliano G., Monno R., Leggio S., Salzillo F., Schena F. P., Leggio A., Renal expression of monocyte chemotactic protein-1 and epidermal growth factor in children with obstructive hydronephrosis. Journal of Pediatric Surgery 2000 35 4 569 572 2-s2.0-12944281825 (Pubitemid 30181029)
174. Torres D. D., Rossini M., Manno C., Mattace-Raso F., D'Altri C., Ranieri E., Pontrelli P., Grandaliano G., Gesualdo L., Schena F. P., The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy. Kidney International 2008 73 3 327 333 2-s2.0-38149128235 10.1038/sj.ki.5002621
175. Bartoli F., Penza R., Aceto G., Niglio F., D'Addato O., Pastore V., Campanella V., Magaldi S., Lasalandra C., Di Bitonto G., Gesualdo L., Urinary epidermal growth factor, monocyte chemotactic protein-1, and β 2-microglobulin in children with ureteropelvic junction obstruction. Journal of Pediatric Surgery 2011 46 3 530 536 2-s2.0-79952274744 10.1016/j.jpedsurg.2010. 07.057
176. Eichenwald E. C., Stark A. R., Management and outcomes of very low birth weight. The New England Journal of Medicine 2008 358 16 1700 1711 2-s2.0-42249089911 10.1056/NEJMra0707601 (Pubitemid 351549917)
177. Koralkar R., Ambalavanan N., Levitan E. B., McGwin G., Goldstein S., Askenazi D., Acute kidney injury reduces survival in very low birth weight infants. Pediatric Research 2011 69 4 354 358 2-s2.0-79952398181 10.1203/PDR.0b013e31820b95ca